NutriBand (NTRB) Current Deferred Revenue (2018 - 2026)
NutriBand's (NTRB) quarterly Current Deferred Revenue came in at $120303.0 in Q1 2026, down 22.82% year-on-year from $155880.0 in Q1 2025, and up 1625.02% quarter-over-quarter from $6974.0 in Q4 2025.
NutriBand (NTRB) Current Deferred Revenue (2018 - 2026) Analysis & Trends
NutriBand has disclosed Current Deferred Revenue across 8 years of filings, most recently posting $120303.0 for Q1 2026.
- Current Deferred Revenue for Q1 2026 came in at $120303.0, down 22.82% year-over-year; the trailing twelve-month figure through Jan 2026 was $120303.0 (down 22.82% YoY), and the FY2026 annual result was $120303.0, down 22.82% from the prior year.
- Current Deferred Revenue came in at $120303.0 for Q1 2026 at NutriBand, up from $6974.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $269345.0 in Q2 2024 to a low of $6974.0 in Q4 2025.
- The 5-year median for Current Deferred Revenue is $157502.0 (2024), against an average of $146805.2.
- Across the five-year window, Current Deferred Revenue jumped 125.51% in 2022 and tumbled 96.81% in 2025, its largest moves.
- NutriBand's Current Deferred Revenue stood at $201990.0 in 2022, then fell by 16.09% to $169495.0 in 2023, then rose by 29.13% to $218868.0 in 2024, then sank by 96.81% to $6974.0 in 2025, then jumped by 1625.02% to $120303.0 in 2026.
- The last three Current Deferred Revenue figures came in at $120303.0 (Q1 2026), $6974.0 (Q4 2025), and $19419.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 120,303.00 |
| Oct 31, 2025 | 6,974.00 |
| Jul 31, 2025 | 19,419.00 |
| Apr 30, 2025 | 44,680.00 |
| Jan 31, 2025 | 155,880.00 |
| Oct 31, 2024 | 218,868.00 |
| Jul 31, 2024 | 179,576.00 |
| Apr 30, 2024 | 269,345.00 |
| Jan 31, 2024 | 157,502.00 |
| Oct 31, 2023 | 169,495.00 |
| Jul 31, 2023 | 217,890.00 |
| Apr 30, 2023 | 188,697.00 |
| Jan 31, 2023 | 162,903.00 |
| Oct 31, 2022 | 201,990.00 |
| Jul 31, 2022 | 145,914.00 |
| Apr 30, 2022 | 129,986.00 |
| Jan 31, 2022 | 106,267.00 |
| Oct 31, 2021 | 239,582.00 |
| Jul 31, 2021 | 64,704.00 |
| Apr 30, 2021 | 69,894.00 |